Cargando…

The Diagnosis of Minimal Change Disease in Diabetic Nephropathy

Proteinuria is common in diabetic patients and usually reflects the presence of diabetic glomerulosclerosis. This paper reviews the differential diagnosis of proteinuria in diabetic patients and discusses the role of renal biopsy examination in identification and management of minimal change disease...

Descripción completa

Detalles Bibliográficos
Autor principal:	Stokes, M. Barry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2005
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936599/ https://www.ncbi.nlm.nih.gov/pubmed/16200329 http://dx.doi.org/10.1100/tsw.2005.106

Ejemplares similares

Diabetic nephropathy; principles of diagnosis and treatment of diabetic kidney disease
por: Nazar, Chaudhary Muhammad Junaid
Publicado: (2014)

Immune Characteristics of IgA Nephropathy With Minimal Change Disease
por: Li, Huixian, et al.
Publicado: (2021)

Classification and Differential Diagnosis of Diabetic Nephropathy
por: Qi, Chenyang, et al.
Publicado: (2017)

Histological changes of kidney in diabetic nephropathy
por: Pourghasem, Mohsen, et al.
Publicado: (2015)

Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
por: Samsu, Nur
Publicado: (2021)

Urinary and plasma proteomics to discover biomarkers for diagnosing between diabetic nephropathy and minimal change nephrotic syndrome or membranous nephropathy
por: Araumi, Akira, et al.
Publicado: (2021)

Splenic Infarction as Starting Symptom in Minimal Change Nephropathy
por: Li, Qiu-Yue, et al.
Publicado: (2017)

The Treatment of Minimal Change Nephropathy and Focal Segmental Glomerulosclerosis
por: Mason, P D
Publicado: (1997)

The Treatment of Minimal Change Nephropathy and Focal Segmental Glomerulosclerosis
por: Milford, D V
Publicado: (1997)

Tubulointerstitial disease in diabetic nephropathy
por: Tonolo, Giancarlo, et al.
Publicado: (2014)

Rapid remission of minimal change disease with angiotensin II antagonist treatment in a type 1 diabetic patient with no diabetic nephropathy
por: Takahashi, Naoki, et al.
Publicado: (2008)

Adult-onset Minimal Change Disease with IgA Nephropathy and Hepatitis C
por: Chowdhury, Waliul, et al.
Publicado: (2018)

Characterization of patients with IgA nephropathy with and without associated minimal change disease
por: Guo, Wei-yi, et al.
Publicado: (2023)

Key pathological features characterize minimal change disease-like IgA nephropathy
por: Wang, Tsung-Yueh, et al.
Publicado: (2023)

Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination
por: Leong, Leanne Ca-Yin, et al.
Publicado: (2021)

What Can Mercury Teach Us About Membranous Nephropathy and Minimal Change Disease?
por: Caza, Tiffany N., et al.
Publicado: (2022)

Diabetic nephropathy
por: Zelmanovitz, Themis, et al.
Publicado: (2009)

Steroid Minimization in Adults with Minimal Change Disease
por: Koirala, Abbal, et al.
Publicado: (2021)

Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change Disease
por: Cho, Won-Hee, et al.
Publicado: (2020)

The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years
por: Martínez-Castelao, Alberto, et al.
Publicado: (2015)

Impact of acute kidney injury on coagulation in adult minimal change nephropathy
por: Huang, Meng-Jie, et al.
Publicado: (2016)

Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes
por: Kim, Sang Soo, et al.
Publicado: (2016)

TIMP3 involvement and potentiality in the diagnosis, prognosis and treatment of diabetic nephropathy
por: Casagrande, Viviana, et al.
Publicado: (2021)

Comparative analysis of diabetic nephropathy and non-diabetic nephropathy disease
por: Chen, Qiuxiang, et al.
Publicado: (2017)

Diabetic Nephropathy without Diabetes
por: López-Revuelta, Katia, et al.
Publicado: (2015)

Relapsing minimal change disease superimposed on late-onset p.N215S Fabry nephropathy
por: Salerno, Fabio R, et al.
Publicado: (2021)

Serum Protein Signatures Using Aptamer-Based Proteomics for Minimal Change Disease and Membranous Nephropathy
por: Muruve, Daniel A., et al.
Publicado: (2022)

The Genetics of Diabetic Nephropathy
por: Brennan, Eoin, et al.
Publicado: (2013)

Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy
por: Campion, Carole G., et al.
Publicado: (2017)

Inflammation in Diabetic Nephropathy
por: Lim, Andy K. H., et al.
Publicado: (2012)

Pathogenesis of diabetic nephropathy
por: Cao, Zemin, et al.
Publicado: (2011)

Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
por: Zürbig, Petra, et al.
Publicado: (2012)

Editorial: Diagnosis, prevention and treatment in diabetic nephropathy
por: Rando, Maria Margherita, et al.
Publicado: (2022)

Diabetes mellitus and diabetic nephropathy: a review of the literature on hemostatic changes in coagulation and thrombosis
por: Alsharidah, Ashwag Saleh
Publicado: (2022)

Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy
por: Salerno, Fabio R, et al.
Publicado: (2022)

IgA nephropathy with minimal change disease associated with primary Sjögren’s syndrome: A case report
por: Choi, Jungyoon, et al.
Publicado: (2023)

Retinal microvascular changes in diabetic patients with diabetic nephropathy
por: Yan, Yujie, et al.
Publicado: (2023)

The gut microbiome in differential diagnosis of diabetic kidney disease and membranous nephropathy
por: Yu, Wei, et al.
Publicado: (2020)

A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood
por: Dekkers, Marinus J, et al.
Publicado: (2015)

Silymarin and diabetic nephropathy
por: Rafieian-Kopaie, Mahmoud, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h61dp2h76ksdl9n4tts0p3rvth